Role of tea catechins in prevention of aging and age-related disorders

키워드

참고문헌 (161)

1. Ahmad N, "Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells", Arch Biochem Biophys, 376, pp.338~346 (2000)
2. Andriollo-Sanchez M, "Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study", Eur J Clin Nutr, 59, pp.S58~S62 (2005)
3. Arts IC, "Chocolate as a source of tea flavonoids", Lancet, 354, pp.488~ (1999)
4. Berletch JB, "Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG", J Cell Biochem, 103, pp.509~519 (2008)
5. Berlett BS, "Protein Oxidation in Aging, Disease, and Oxidative Stress", J Biol Chem, 272, pp.20313~20316 (1997)
6. Bernardi P, "A mitochondrial perspective on cell death", Trends Biochem Sci, 26, pp.112~117 (2001)
7. Bettuzzi S, "Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with High-Grade Prostate Intraepithelial Neoplasia: A preliminary report from a one-year proof-of-principle study", Cancer Res, 66, pp.1234~1240 (2006)
8. Bickford P, "Impaired acquisition of novel locomotor tasks in aged and norepinephrine-depleted F344 rats", Neurobiol Aging, 13, pp.475~481 (1992)
9. Bickford P, "Motor learning deficits in aged rats are correlated with loss of cerebellar noradrenergic function", Brain Res, 620, pp.133~138 (1993)
10. Bu-Abbas A, "Marked antimutagenic potential of aqueous green tea extracts: mechanism of action", Mutagenesis, 9, pp.325~331 (1994)
11. Bucala R, "Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes", J Clin Invest, 87, pp.432~438 (1991)
12. Burgess ML, "Age-associated changes in cardiac matrix and integrins", Mech Ageing Dev, 122, pp.1739~1756 (2001)
13. Cao J, "Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis", Fundam Appl Toxicol, 29, pp.244~250 (1996)
14. Carter HB, "Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease", Urology, 53, pp.126~130 (1999)
15. Checkoway H, "Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake", Am J Epidemiol, 155, pp.732~738 (2002)
16. Choi JY, "Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease in mice by tea phenolic epigallocatechin 3-gallate", Neurotoxicol, 23, pp.367~374 (2002)
17. Chow HH, "Pharmacokinetic and chemoprevention studies on tea in humans", Pharmacol Res, 64, pp.105~112 (2011)
18. Cory S, "The Bcl2 family: Regulators of the cellular life-or-death switch", Nat Rev Cancer, 2, pp.647~656 (2002)
19. Devan BD, "Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze", Neurobiol Learn Mem, 66, pp.305~323 (1996)
20. Dhalla NS, "Role of oxidative stress in cardiovascular diseases", J Hypertens, 18, pp.655~673 (2000)
21. Dyer DG, "Accumulation of Maillard reaction products in skin collagen in diabetes and aging", J Clin Invest, 91, pp.2463~2469 (1993)
22. El Bedoui J, "Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression", Cardio Res, 67, pp.317~325 (2005)
23. Erba D, "Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans", J Nutr Biochem, 16, pp.144~149 (2005)
24. Esterbauer H, "Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes", J Lipid Res, 28, pp.495~509 (1987)
25. Gao YT, "Reduced risk of esophageal cancer associated with green tea consumption", J Natl Cancer Inst, 86, pp.855~858 (1994)
26. Gerlach M, "Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson’s disease", Neurotox Res, 5, pp.35~44 (2003)
27. Gokulakrisnan A, "Attenuation of cardiac oxidative stress by (-)-epigallocatechin-gallate(EGCG) in CS exposed rats", Biomed Pharmacother (2010)
28. Gotz ME, "Oxidative stress: a role in the pathogenesis of Parkinson’s disease", J Neural Transm, 29, pp.241~249 (1990)
29. Graham HN, "Green tea composition, consumption, and polyphenol chemistry", Prev Med, 21, pp.334~350 (1992)
30. Gutteridge JM, "Free radicals in disease processes: a compilation of cause and consequence", Free Radic Res Commun, 19, pp.141~158 (1993)
31. Hakim IA, "Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study", J Nutr, 133, pp.3303~3309 (2003)
32. Halliwell B, "Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts", Arch Biochem Biophys, 246, pp.501~514 (1986)
33. Hammerstone JF, "Procyanidin content and variation in some commonly consumed foods", J Nutr, 130, pp.2086S~2092S (2000)
34. Harman D, "Free radical involvement in aging. Pathophysiology and therapeutic implications", Drug Aging, 3, pp.60~80 (1993)
35. Harman D, "Free-radical theory of aging. Increasing the functional life span", Ann N Y Acad Sci, 717, pp.1~15 (1994)
36. Hayakawa S, "Apoptosis induction by epigallocatechin gallate involves its binding to Fas", Biochem Biophys Res Commun, 285, pp.1102~1106 (2001)
37. Hibasami H, "Induction of apoptosis in human stomach cancer cells by green tea catechins", Oncol Rep, 5, pp.527~529 (1998)
38. Hindmarch I, "A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality", Psychopharmacol, 149, pp.203~216 (2000)
39. -pyridine (PhIP).-induced mammary gland carcinogenesis by antioxidants in F344 female rats, "Carcinogenesis", 1995, 217~221
40. Hoshiyama Y, "A nested case–control study of stomach cancer in relation to green tea consumption in Japan", Br J Cancer, 90, pp.135~138 (2004)
41. Ichikawa D, "Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1", Biol Pharm Bull, 27, pp.1353~1358 (2004)
42. Inagake M, "Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage by green tea extract in rat", Jpn J Cancer Res, 86, pp.1106~1111 (1995)
43. Inal ME, "Antioxidant enzyme activities and malondialdehyde levels related to aging", Clin Chim Acta, 305, pp.75~80 (2001)
44. Jain M, "Alcohol and other beverage use and prostate cancer risk among Canadian men", Int J Cancer, 78, pp.707~711 (1998)
45. Janqueira VB, "Aging and oxidative stress", Mol Aspects Med, 25, pp.5~16 (2004)
46. Ji BT, "Green tea consumption and the risk of pancreatic and colorectal cancers", Int J Cancer, 70, pp.255~258 (1997)
47. Joseph JA, "Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation", Neurobiol. Aging, 4, pp.313~319 (1983)
48. Jung YD, "EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells", Br J Cancer, 84, pp.844~850 (2001)
49. Kanai H, "Close correlation of intra-abdominal fat accumulation to hypertension in obese women", Hypertension, 16, pp.484~490 (1990)
50. Kang WS, "ntithrombotic Activities of Green Tea Catechins and (-)-Epigallocatechin Gallate", Thromb Res, 96, pp.229~237 (1999)
51. Kim NW, "Specific association of human telomerase activity with immortal cells and cancer", Science, 266, pp.2011~2115 (1994)
52. Kluger A, "Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer’s disease", J Gerontol B Psychol Sci Soc Sci, 52, pp.28~39 (1997)
53. Koga T, "Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells", Am J Clin Nutr, 73, pp.941~948 (2001)
54. Kumar N, "Concentration-dependent effect of (-) epicatechin in hypertensive patients", Phytother Res, 24, pp.1433~1436 (2010)
55. Kuroda Y, "Antimutagenic and anticarcinogenic activity of tea polyphenols", Mutat Res, 436, pp.69~97 (1999)
56. Lakatta EG, "Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: A "set up" for vascular disease", Circulation, 107, pp.139~146 (2003)
57. Lakatta EG, "Cardiovascular regulatory mechanisms in advanced age", Physiol Rev, 73, pp.413~467 (1993)
58. Lambert JD, "The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention", Arch Biochem Biophys, 501, pp.65~72 (2010)
59. Lee MJ, "Yang CS. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans : Formation of different metabolites and individual variability", Cancer Epidemiol Biomarkers Prev, 11, pp.1025~1032 (2002)
60. Levites Y, "Neuroprotection and neurorescue against amyloid beta toxicity and PKC-dependent release of non-amyloidogenic soluble precursor protein by green tea polyphenol (-)epigallocatechin-3-gallate", FASEB J, 17, pp.952~954 (2003)
61. Levites Y, "Involvement of protein kinase C activation and cell survival", cell cycle genes in green tea polyphenol (–)-epigallocatechin-3-gallate neuroprotective action, 2002, pp.277, 30574~30580
62. Levites Y, "Green tea polyphenol (–)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration", J Neurochem, 78(5), pp.1073~1082 (2001)
63. Li HL, "Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways", Free Radic Biol Med, 40, pp.1756~1775 (2006)
64. Li Q, "Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL", 6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade, 2009, pp.159, 1208~1215
65. Liao S, "Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate", Cancer Lett, 96, pp.239~243 (1995)
66. Lim GP, "The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse", J Neurosci, 21, pp.8370~8377 (2001)
67. Lin J, "Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms", Exp Gerontol, 43, pp.296~306 (2008)
68. Locher R, "Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein", Eur J Pharmacol, 434, pp.1~7 (2002)
69. Luczaj W, "Green tea protection against age-dependent ethanol-induced oxidative stress", J Toxicol Environ Health A, 67, pp.595~606 (2004)
70. Su-Yun Lyu, "Production of Cytokine and NO by RAW 264.7 Macrophages and PBMC In Vitro Incubation with Flavonoids", Archives of Pharmacal Research, 28(5), pp.573~581 (2005), 대한약학회
71. Manach C, "Polyphenols: food sources and bioavailability", Am J Clin Nutr, 79, pp.727~747 (2004)
72. Mandel S, "Iron and alpha-synuclein in the substantia Nigra of MPTP-treated mice: Effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate", J Mol Neurosci, 24, pp.401~416 (2004)
73. Mandel SA, "Multifunctional Activities of Green Tea Catechins in Neuroprotection-Modulation of Cell Survival Genes, Iron-Dependent Oxidative Stress and PKC Signaling Pathway", Neurosignals, 14, pp.46~60 (2005)
74. Maridonneau I, "Na+ and K+ transport damage induced by oxygen free radicals in human red cell membranes", J Biol Chem, 25, pp.3107~31013 (1983)
75. Masuda M, "Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines", Clin Cancer Res, 7, pp.4220~4229 (2001)
76. Matsumoto H, "Inhibition of mucosal lipid hyperoxidation by green tea extract in 1,2-dimethylhydrazine-induced rat colonic carcinogenesis", Cancer Lett, 104, pp.205~209 (1996)
77. Matsuoka Y, "Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries", J Pharmacol Exp Ther, 274, pp.602~608 (1995)
78. Mattson MP, "Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer’s disease", Brain Res Rev, 23, pp.47~61 (1997)
79. Maurya PK, "Role of L-ascorbic acid in the stability of human erythrocytes during aging in humans", Indian J Gerontol, 23, pp.1~9 (2009)
80. Maurya PK, "Age-associated changes in erythrocyte glutathione peroxidase activity: correlation with total antioxidant potential", Indian J Biochem Biophys, 47, pp.319~321 (2010)
81. Maurya PK, "Intracellular uptake of (-) epicatechin by human erythrocytes as a function of human age", Phytotherapy Res, 25, pp.944~946 (2011)
82. Maurya PK, "Age dependent changes in glutathione-S-transferase: correlation with total total antioxidant potential and red cell intracellular glutathione", Indian J Clin Biochem, 25, pp.398~400 (2010)
83. Maurya PK, "Alterations in plasma nitric oxide during aging in humans", Indian J Biochem Biophys, 46, pp.130~132 (2009)
84. Maurya PK, "Protective role of tea catechins on erythrocytes subjected to oxidative stress during human aging", Nat Prod Res, 23, pp.1072~1079 (2009)
85. McDonald RJ, "Parallel information processing in the water maze : evidence for independent memory systems involving dorsal striatum and hippocampus", Behav Neural Biol, 61, pp.260~270 (1994)
86. Melov S, "Animal models of oxidative stress, aging and therapeutic antioxidant interventions", Int J Biochem Cell Biol, 34, pp.1395~1400 (2002)
87. Mittal A, "EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis", Int J Oncol, 24, pp.703~710 (2004)
88. Miura Y, "Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans", J Nutr Biochem, 11, pp.216~222 (2000)
89. Mohan S, "Age related changes in muscle protein degradation", Mech Ageing Dev, 7, pp.81~87 (1978)
90. Morales CP, "Absence of cancer-associated changes in human fibroblasts immortalized with telomerase", Nat Genet, 21, pp.115~118 (1999)
91. Nagao T, "A green tea extract high in catechins reduces body fat and cardiovascular risks in humans", Obesity, 15, pp.1473~1483 (2007)
92. Nagata H, "Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase", Tokai J Exp Clin Med, 24, pp.1~11 (1999)
93. Nakachi K, "Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients", Jpn J Cancer Res, 89, pp.254~261 (1998)
94. Nam S, "Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo", J Biol Chem, 276, pp.13322~13330 (2001)
95. Oliver CN, "Goldstein S, Stadtman ER. Age-related changes in oxidized proteins", J Biol Chem, 262, pp.5488~5491 (1987)
96. Ono K, "Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro : Implications for the prevention and therapeutics of Alzheimer’s disease", J Neurochem, 87, pp.172~181 (2003)
97. Osada K, "Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro", Comp Biochem Physiol C Toxicol Pharmacol, 128, pp.153~164 (2001)
98. Packham MA, "Role of platelets in thrombosis and hemostasis", Can J Physiol Pharmacol, 72, pp.278~284 (1994)
99. Pan T, "Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury", Life Sci, 72, pp.1073~1083 (2003)
100. Pandey KB, "Plasma protein oxidation and its correlation with antioxidant potential during human aging", Dis Markers, 29, pp.31~36 (2010)
101. Paschka AG, "Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate", Cancer Lett, 130, pp.1~7 (1998)
102. Perry G, "Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response", Comp Biochem Physiol C Toxicol Pharmacol, 133(4), pp.507~513 (2002)
103. Ramassamy C, "Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets", Eur J Pharmacol, 545, pp.51~64 (2006)
104. Ramesh E, "Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis", Chem Biol Interact, 183, pp.125~132 (2010)
105. Raza H, "In vitro protection of reactive oxygen species-induced degradation of lipids, proteins and 2-deoxyribose by tea catechins", Food Chem Toxicol, 45, pp.1814~1820 (2007)
106. Reiter RJ, "Acuna-Castroviejo D. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin", Ann N Y Acad Sci, 854, pp.410~424 (1998)
107. Riederer P, "Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains", J Neurochem, 52, pp.515~520 (1989)
108. Rizvi SI, "Markers of oxidative stress in erythrocytes during aging in humans", Ann N Y Acad Sci, 1100, pp.373~382 (2007)
109. Rizvi SI, "Erythrocyte plasma membrane redox system in human aging", Rejuvenation Res, 9, pp.490~494 (2006)
110. Rizvi SI, "Alterations in antioxidant enzymes during aging in humans", Mol Biotechnol, 27, pp.58~61 (2007)
111. Rizvi SI, "L-cysteine influx in erythrocytes as a function of human age", Rejuvenation Res, 11, pp.661~665 (2008)
112. Rizvi SI, "Ascorbate recycling by erythrocytes during aging in humans", Rejuvenation Res, 12, pp.3~6 (2009)
113. Rogers JT, "An iron-responsive element type II in the 5׳-untranslated region of the Alzheimer’s amyloid precursor protein transcript", J Biol Chem, 277, pp.45518~45528 (2002)
114. Ruidavets J, "Catechin in the Mediterranean diet: vegetable, fruit or wine", Atherosclerosis, 153, pp.107~117 (2000)
115. Sachinidis A, "Inhibition of the PDGF β-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins", FASEB J, 16, pp.893~895 (2002)
116. Sadava D, "The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells", Biochem Biophys Res Commun, 360, pp.233~237 (2007)
117. Salah N, "Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants", Arch Biochem Biophys, 322, pp.339~346 (1995)
118. Sanae F, "Effects of catechins on vascular tone in rat thoracic aorta with endothelium", Life Sci, 71, pp.2553~2562 (2002)
119. Sanna B, "Direct and indirect interactions between calcineurin-NFAT and MEK1- extracellular signal-regulated kinase 1", 2 signaling pathways regulate cardiac gene expression and cellular growth, 2005, pp.25, 865~878
120. Santangelo C, "Polyphenols, intracellular signalling and inflammation", Ann Ist Super Sanita, 43, pp.394~405 (2007)
121. Seeram NP, "Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins", Nutr Cancer, 46, pp.101~106 (2003)
122. Shay JW, "Telomerase and cancer", Hum Mol Genet, 10, pp.677~685 (2001)
123. Shimizu M, "(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells", Clin. Cancer Res, 11, pp.2735~2746 (2005)
124. Shukitt-Hale B, "Berry Fruit Supplementation and the Aging Brain", J Agric. Food Chem, 56, pp.636~641 (2008)
125. Shukitt-Hale B, "Psychomotor and spatial memory performance in aging male Fischer 344 rats", Exp Gerontol, 33, pp.615~624 (1998)
126. Shukitt-Hale B, "The effects of aging and oxidative stress on psychomotor and cognitive behavior", Age, 22, pp.9~17 (1999)
127. Smith CD, "Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease", Proc Natl Acad Sci USA, 88, pp.10540~10543 (1991)
128. Son DJ, "Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway", Prostaglandins Leukot Essent Fatty Acids, 71, pp.25~31 (2004)
129. Song DU, "Effect of Drinking Green Tea on Age-Associated Accumulation of Maillard-Type Fluorescence and Carbonyl Groups in Rat Aortic and Skin Collagen", Arch Biochem Biophys, 397, pp.424~429 (2002)
130. Stangl V, "Molecular targets of tea polyphenols in the cardiovascular system", Cardiovasc Res, 73, pp.348~358 (2007)
131. Starke-Reed PE, "Protein oxidation and proteolysis during aging and oxidative stress", Arch Biochem Biophys, 275, pp.559~567 (1989)
132. Steinberg D, "Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity", N Engl J Med, 320, pp.915~924 (1989)
133. Subramanian N, "Role of polyphenol oxidase and peroxidase in the generation of black tea theaflavins", J Agric Food Chem, 47, pp.2571~2578 (1999)
134. (-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue, "Carcinogenesis", 1998, 1771~1776
135. Sugisawa A, "Anti-genotoxic effects of tea catechins against reactive oxygen species in human lymphoblastoid cells", Mutat Res, 559, pp.97~103 (2004)
136. Sutherland BA, "Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration", J Nutr Biochem, 17, pp.291~306 (2006)
137. Tournaire C, "Antioxidant activity of flavonoids: Efficiency of singlet oxygen (1Δg) quenching", J Photochem Photobiol B, 19, pp.205~215 (1993)
138. Upaganlawar A, "Effect of vitamin E and green tea on hemodynamic, electrocardiographic and some biochemical alterations in experimentally induced myocardial infarction in rats", Eur J Integrative Med, 2, pp.135~141 (2010)
139. van Acker SA, "Structural aspects of antioxidant activity of flavonoids", Free Radic Biol Med, 20, pp.331~342 (1996)
140. Velayutham P, "Green Tea Catechins and Cardiovascular Health: An Update", Curr Med Chem, 15, pp.1840~1850 (2008)
141. Verma S, "C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation", Am J Physiol Regul Integr Comp Physiol, 285, pp.R1253~R1256 (2003)
142. Virmani R, "Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis: comparison between occidental and Chinese communities", Am J Pathol, 139, pp.1119~1129 (1991)
143. Vlassara H, "Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging", Lab Inves, 70, pp.138~151 (1994)
144. Wakai K, "Aoki K: Prognostic significance of selected lifestyle factors in urinary bladder cancer", Jpn J Cancer Res, 84, pp.1223~1229 (1993)
145. Wang CH, "C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle", Circulation, 107, pp.1783~1790 (2003)
146. anthracene-initiated SKH-1 mice, "Cancer Res", 1994, 3428~3435
147. Wang ZY, "Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols", Carcinogenesis, 10, pp.411~415 (1989)
148. Weinreb O, "Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases", J Nutr Biochem, 15, pp.506~516 (2004)
149. West RL, "An application of pre-frontal cortex function theory to cognitive aging", Psychol Bull, 120, pp.272~292 (1996)
150. Wiseman H, "Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer", Biochem J, 313, pp.17~29 (1996)
151. Wolff VJ, "Age-related reduction of the RNA content of rat cardiac muscle and cerebellum", Arch Biochem Biophys, 95, pp.181~182 (1961)
152. Xu Y, "Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A", J mice by green tea and its major polyphenol as antioxidants, 1992, pp.52, 3875~3879
153. Yamamoto A, "Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer’s disease", J Neurochem, 82, pp.1137~1147 (2002)
154. Yamane T, "Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis", Cancer, 77, pp.1662~1667 (1996)
155. Youdim KA, "A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects", Free Radic Biol Med, 30, pp.583~594 (2001)
156. Youdim MB, "Ironing iron out in Parkinson’s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28", Ann N Y Acad Sci, 1012, pp.306~325 (2004)
157. Zaveri NT, "Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications", Life Sci, 78, pp.2073~2080 (2006)
158. Zhang G, "Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats", Biosci Biotechnol Biochem, 66, pp.711~716 (2002)
159. Zhong L, "A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China", Epidemiology, 12, pp.695~700 (2001)
160. Zhou YD, "Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts", J Nat Prod, 67, pp.2063~2069 (2004)
161. Zhu M, "Green tea and its major components ameliorate immune dysfunction in mice bearing Lewis lung carcinoma and treated with the carcinogen NNK", Nutr Cancer, 35, pp.64~72 (1999)

관련 논문AI추천